Related Experiment Video

Updated: Aug 9, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Inhibition of Na-K-ATPase activity and gene expression by a myeloma light chain in proximal tubule cells

S Guan1, S el-Dahr, S Dipp

  • 1Department of Medicine, Nephrology Section, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|November 26, 1999
PubMed
Abstract

Insights

Lambda light chains from multiple myeloma can harm kidney cells. This study shows they significantly reduce sodium-potassium pump (Na-K-ATPase) activity and gene expression in rat kidney cells, contributing to toxicity.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Light chain nephrotoxicity is linked to Fanconi syndrome, causing kidney transport defects.
  • The exact mechanisms behind these transport abnormalities remain unclear.
  • Investigating the role of sodium-potassium ATPase (Na-K-ATPase) is crucial for understanding light chain toxicity.

Purpose of the Study:

  • To determine the effect of a specific lambda light chain on Na-K-ATPase activity and gene expression.
  • To elucidate the role of Na-K-ATPase in light chain-induced proximal tubule cell damage.

Main Methods:

  • Primary rat proximal tubule cells were cultured and exposed to isolated lambda light chain.
  • Na-K-ATPase activity was measured spectrophotometrically.
  • Gene expression of Na-K-ATPase and other cellular markers was analyzed using Northern blotting.

Main Results:

  • Lambda light chain significantly reduced Na-K-ATPase activity by up to 73% over 48 hours.
  • Gene expression of the Na-K-ATPase alpha-1 isoform was significantly suppressed.
  • Light chain exposure also inhibited cell proliferation (thymidine incorporation) in a dose-dependent manner.

Conclusions:

  • The studied lambda light chain exhibits general cytotoxicity to proximal tubule cells.
  • Inhibition of Na-K-ATPase activity and gene expression is a key mechanism of light chain cytotoxicity.
  • These findings provide insight into the pathogenesis of light chain nephrotoxicity.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...